Patents by Inventor Malcolm Philip Young

Malcolm Philip Young has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180042891
    Abstract: There is described a therapeutic agent capable of directly or indirectly having an effect on the proteins N-methyl-D-aspartate (NMDA), Cyclooxygenase-2 (COX-2), Tumour Necrosis factor alpha (TNF-a), Nuclear factor-kappa B (NF?B), Cyclin-dependent kinases, e.g. CDK2/A and CDK5/p25, Histone acetyltransferase (HAT) and Farnesyltransferase, simultaneously, sequentially or separately. There is especially described dexanabinol, or a derivative thereof, as the therapeutic agent.
    Type: Application
    Filed: October 3, 2017
    Publication date: February 15, 2018
    Applicant: e-Therapeutics plc
    Inventors: Malcolm Philip Young, Philip McKeown
  • Publication number: 20150093438
    Abstract: There is described a sub-analgesic amount of tramadol, or a salt thereof, in the treatment, alleviation or prevention of depression in a patient wherein the sub-analgesic amount is from about 60 to 80 mg, of tramadol or a salt thereof.
    Type: Application
    Filed: May 3, 2013
    Publication date: April 2, 2015
    Inventors: Malcolm Philip Young, Philip McKeown
  • Publication number: 20150072020
    Abstract: There is described a method of treating cancer in a patient wherein the method comprises the administration of dexanabinol, or a derivative thereof, in an amount of from about 2 mg/kg to about 30 mg/kg, based on the weight of the patient.
    Type: Application
    Filed: April 26, 2013
    Publication date: March 12, 2015
    Applicant: E-THERAUPEUTICS PLC
    Inventors: Malcolm Philip Young, Philip McKeown
  • Patent number: 8614179
    Abstract: There is described a composition comprising a therapeutically active imidazole, and derivatives thereof, and an agent active on a bacterial cell surface selected from the group consisting of one or more of colistin, nisin, D-cycloserine, fosfomycin, fosfomycin trometamol, fosfomycin disodium and polymixin B, and derivatives thereof.
    Type: Grant
    Filed: July 17, 2009
    Date of Patent: December 24, 2013
    Assignee: E-Therapeutics PLC
    Inventors: Malcolm Philip Young, Catherine Mary Thomas
  • Publication number: 20130296437
    Abstract: There is described a method of treatment of a patient suffering from depression, said method comprising the administration of a sub-analgesic amount of tramadol, or a salt thereof.
    Type: Application
    Filed: March 5, 2013
    Publication date: November 7, 2013
    Applicant: e-Therapeutics plc
    Inventors: Malcolm Philip Young, Philip McKeown
  • Publication number: 20120190735
    Abstract: There is described a therapeutic agent capable of directly or indirectly having an effect on the proteins N-methyl-D-aspartate (NMDA), Cyclooxygenase-2 (COX-2), Tumour Necrosis factor alpha (TNF-a), Nuclear factor-kappa B (NFKB), Cyclin-dependent kinases, e.g. CDK2/A and CDK5/p25, Histone acetyltransferase (HAT) and Farnesyltransferase, simultaneously, sequentially or separately. There is especially described dexanabinol, or a derivative thereof, as the therapeutic agent.
    Type: Application
    Filed: September 10, 2010
    Publication date: July 26, 2012
    Applicant: E-THERAPEUTICS PLC
    Inventors: Malcolm Philip Young, Philip McKeown
  • Publication number: 20110257078
    Abstract: There is described a composition comprising a therapeutically active imidazole, and derivatives thereof, and an agent active on a bacterial cell surface selected from the group consisting of one or more of colistin, nisin, D-cycloserine, fosfomycin, fosfomycin trometamol, fosfomycin disodium and polymixin B, and derivatives thereof.
    Type: Application
    Filed: July 17, 2009
    Publication date: October 20, 2011
    Applicant: E-THERAPEUTICS PLC
    Inventors: Malcolm Philip Young, Catherine Mary Thomas
  • Publication number: 20110212173
    Abstract: There is described a pharmaceutical composition for controlled release of an active compound wherein the active compound is selected from the group comprising tramadol, resveratrol, acetaminophen, xorphanol, cinfenoac, furcloprofen, bismuth subsalicylate, enofelast, triflusal, ketorfanol, indriline, furofenac, cizolirtine, dacemazine, demelverine, and fenethazine, and derivatives and/or combinations thereof for the treatment or alleviation of depression. More particularly, there is described an abuse resistant pharmaceutical composition for the treatment of inter alia, depression and controlled release pharmaceutical compositions of related thereto.
    Type: Application
    Filed: June 17, 2009
    Publication date: September 1, 2011
    Applicant: e-Therapeutics Ple
    Inventors: Malcolm Philip Young, Olusola Clement Idowu, Philip McKeown
  • Publication number: 20110039906
    Abstract: There is described a composition comprising a therapeutically active imidazole, or a derivative thereof, and disulfiram, or a derivative thereof, for treating an infection contributed to or caused by multi-drug resistant bacterial species.
    Type: Application
    Filed: July 18, 2008
    Publication date: February 17, 2011
    Applicant: E-THERAPEUTICS PLC
    Inventors: Malcolm Philip Young, Catherine Mary Thomas, Olusola Clement Idowu, Julie Anne Charlton
  • Publication number: 20110033376
    Abstract: There is described dexanabinol, or a derivative thereof, for the treatment of melanoma. There is also described a method of treating a patient suffering from melanoma.
    Type: Application
    Filed: July 4, 2008
    Publication date: February 10, 2011
    Inventors: Malcolm Philip Young, Catherine Mary Thomas, Olusola Clement Idowu, Julie Anne Charlton
  • Publication number: 20110034480
    Abstract: There is described a pharmaceutical composition comprising a therapeutically effective amount of cetirizine, or a pharmaceutically acceptable derivative thereof, and a therapeutically effective amount of one or more compounds selected from the group consisting of a non beta-2-adrenoreceptor agonist; a beta-2-adrenoreceptor agonist and an anti-inflammatory agent; in admixture with a pharmaceutically acceptable adjuvant, diluent or carrier.
    Type: Application
    Filed: October 3, 2008
    Publication date: February 10, 2011
    Inventors: Malcolm Philip Young, Roy Drucker
  • Publication number: 20110020217
    Abstract: There is described a pharmaceutical composition comprising dexanabinol, or a derivative thereof, in combination with a second therapeutic agent that targets BRAF or MEK, and a pharmaceutically acceptable adjuvant, diluent or carrier. There is also described a method of treating a patient suffering from melanoma and uses related thereto.
    Type: Application
    Filed: October 10, 2008
    Publication date: January 27, 2011
    Applicant: E-THERAPEUTICS PLC
    Inventors: Malcolm Philip Young, Catherine Mary Thomas, Olusola Clement Idowu
  • Publication number: 20100144626
    Abstract: There is described an imidazole for the treatment of an infection caused or contributed to by microorganisms resistant to antibiotics. There is also described a method of treating a patient suffering from an infection caused or contributed to by microorganisms resistant to antibiotics, said method comprising the step of administering an effective amount of an imidazole.
    Type: Application
    Filed: November 15, 2007
    Publication date: June 10, 2010
    Inventors: Malcolm Philip Young, Catherine Mary Thomas, Olusola Clement Idowu, Julie Anne Charlton
  • Publication number: 20090005443
    Abstract: There is described a compound selected from the group consisting of tramadol, resveratrol, acetaminophen, xorphanol, cinfenoac, furcloprofen, bismuth subsalicylate, enofelast, triflusal, ketorfanol, indriline, furofenac, cizolirtine, dacemazine, demelverine, and fenethazine, and derivatives and/or combinations thereof, for the treatment or alleviation of depression. There is also described a method of treating a patient suffering from depression.
    Type: Application
    Filed: June 20, 2008
    Publication date: January 1, 2009
    Inventors: Malcolm Philip Young, Catherine Mary Yates, Olusola Clement Idowu, Julie Anne Charlton